Evolut R Implantation to Treat Severe Pure Aortic Regurgitation in a Patient With Mitral Bioprosthesis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 27847071.
- Also identified by DOI 10.1016/j.athoracsur.2016.05.054.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transcatheter aortic valves have been designed to treat high-risk surgical candidates affected by severe aortic stenosis, but little is known about the use of transcatheter valves in patients with severe pure aortic regurgitation. We describe the implantation of Medtronic CoreValve Evolut R (Medtronic, Minneapolis, MN) to treat an 82-year-old patient affected by severe pure aortic regurgitation who underwent prior mitral valve replacement with a biological valve protruding into the left ventricular outflow tract.
Medical subject headings
- Aortic Valve Insufficiency
- Bioprosthesis
- Heart Valve Prosthesis
- Heart Valve Prosthesis Implantation
- Mitral Valve Insufficiency